Prelude Therapeutics Incorporated: JP Morgan initiates coverage with overweight rating; price target $12
PRLD•Related News
Technicals-US oil may retest support at $100.98
XLE•
Puma Biotechnology director Alessandra Cesano disposes of 62,150 common shares worth $566,437.45
PBYI•
TransDigm Group Incorporated: JP Morgan cuts target price to $1415 from $1450
TDG•
Alpha Teknova, Inc. <TKNO.O>: Jefferies initiates coverage with Buy rating; price target $9
TKNO•
South Korea foreign minister says Hormuz Strait military deployment not decided
XLE•